Open AccessPotential use of lapatinib in the treatment of head and neck squamous cell carcinoma (Review)
Author(s) -
Christina Healthyni,
Toto Subroto,
Sandra Megantara,
Supat Jiranusornkul,
Jutti Levita
Publication year - 2022
Publication title -
world academy of sciences journal
Language(s) - English
Resource type - Journals
eISSN - 2632-2919
pISSN - 2632-2900
DOI - 10.3892/wasj.2022.170
Subject(s) - afatinib , cetuximab , lapatinib , medicine , head and neck squamous cell carcinoma , epidermal growth factor receptor , tyrosine kinase inhibitor , tyrosine kinase , oncology , cancer research , egfr inhibitors , pharmacology , receptor , head and neck cancer , erlotinib , radiation therapy , cancer , trastuzumab , breast cancer , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom